Low cost of switching suppliers (GlaxoSmithKline)

Last Updated by Anonymous | Update This Page Flag this page Delete This Page

rating: 0+x

The easier it is to switch suppliers, the less bargaining power they have. Low supplier switching costs positively affect GlaxoSmithKline. … "Low cost of switching suppliers (GlaxoSmithKline)" has a significant impact, so an analyst should put more weight into it. "Low cost of switching suppliers (GlaxoSmithKline)" will have a long-term positive impact on the this entity, which adds to its value. "Low cost of switching suppliers (GlaxoSmithKline)" is an easily defendable qualitative factor, so competing institutions will have a difficult time overcoming it. This statements will have a short-term negative impact on this entity, which subtracts from its value. This qualitative factor will lead to an increase in costs. This statement will lead to a decrease in profits. "Low cost of switching suppliers (GlaxoSmithKline)" is an easy qualitative factor to overcome, so the investment will not have to spend much time trying to overcome this issue.

Affected Investments